scispace - formally typeset
G

George O. Angheloiu

Researcher at Cleveland Clinic

Publications -  16
Citations -  340

George O. Angheloiu is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Coronary artery disease & Coronary atherosclerosis. The author has an hindex of 7, co-authored 15 publications receiving 333 citations. Previous affiliations of George O. Angheloiu include Massachusetts Institute of Technology & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis

TL;DR: In situ proteomic evidence is provided consistent with the "iron hypothesis," which proposes an association between excessive iron storage and a high risk of CAD, and suggests that increased expression of the ferritin light chain may contribute to pathogenesis of CAD by modulating oxidation of lipids within the vessel wall through the generation of reactive oxygen species.
Journal ArticleDOI

Identification of new genes differentially expressed in coronary artery disease by expression profiling.

TL;DR: Large-scale gene expression analysis of approximately 12,000 human genes in nine severely atherosclerotic and six nonatherosclerosis human coronary arteries identified 56 genes whose expression is associated with CAD, and 49 of them may represent new genes linked to CAD.
Journal ArticleDOI

Detection of morphological markers of vulnerable atherosclerotic plaque using multimodal spectroscopy

TL;DR: Evidence is presented that multimodal spectroscopy (MMS) provides depth-sensitive and complementary morphological information about plaque composition and a prospective in vivo study will be conducted to validate these findings.

Detection of morphological markers of vulnerable atherosclerotic plaque using multimodal spectroscopy

TL;DR: In this paper, a multimodal spectroscopy method that combines diffuse reflectance spectroscopy (DRS), intrinsic fluorescence spectro-spectroscopy IFS, and Raman Spectroscopy RS was proposed to detect plaque vulnerability.